对侧乳房 augmentation 对直接植入式乳房再造并发症的影响
该回顾性研究纳入2013年1月至2017年7月行单侧即刻直接植入式(DTI)乳房再造的121例患者,其中21例(17.4%)同期行对侧乳房 augmentation。结果显示对侧 augmentation 组与未 augmentation 组的总体并发症(23.8% vs. 31%,p=0.512)及皮瓣坏死率(14.3% vs. 18.0%,p>0.999)均无显著差异,多因素分析中对侧 augmentation 与并发症发生无关。
要点
- 单侧即刻DTI乳房再造同期行对侧 augmentation 不增加总体并发症风险。
- 对侧 augmentation 组皮瓣坏死率为14.3%,与未 augmentation 组18.0%无显著差异。
- 多因素分析中仅乳房切除重量为并发症预测因素(p=0.053)。
核心结论
- 在直接植入式乳房再造中,对侧乳房 augmentation 不是并发症的危险因素,可在选定患者中安全实施。
研究设计与样本
- 回顾性病历回顾研究,纳入2013年1月至2017年7月行单侧即刻直接植入式乳房再造的121例患者。
主要发现
- 对侧 augmentation 组21例(17.4%),未 augmentation 组100例(82.6%)。
- 总体并发症发生率两组分别为23.8%与31%,p=0.512。
- 皮瓣坏死发生率对侧 augmentation 组为14.3%,未 augmentation 组为18.0%,p>0.999。
- 多因素分析中乳房切除重量是并发症的唯一预测因素(p=0.053),对侧 augmentation 与并发症发生无关。
临床怎么用
- 在选定患者中,单侧即刻DTI乳房再造可同期安全行对侧乳房 augmentation。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Simultaneous contralateral augmentation in direct-to-implant (DTI) breast reconstruction may increase the risk of skin flap necrosis on the reconstruction side due to increased tension on the skin flap when implants are larger than the original breast size. The purpose of this study was to evaluate whether the contralateral augmentation procedure affects complications in unilateral DTI breast reconstruction. METHODS: Patients who underwent immediate unilateral DTI breast reconstruction from January 2013 to July 2017 were included in this study. Data were collected through retrospective review of individual medical records. The primary outcome variable was the development of perioperative complications including skin flap necrosis. Univariable and multivariable logistic regression analyses were performed to identify risk factors for complications. RESULTS: A total of 121 patients who underwent unilateral immediate DTI breast reconstruction were included in this study. Twenty-one patients (17.4%) underwent simultaneous contralateral augmentation mammoplasty and 100 patients (82.6%) underwent DTI without contralateral augmentation. Overall complications were not different between the contralateral augmentation and no-augmentation groups (23.8% vs. 31%, respectively, p = 0.512). The frequency of skin flap necrosis in the augmentation group (14.3%) was not significantly different from that in the no-augmentation group (18.0%, p > 0.999). In multivariable analysis, mastectomy weight was the only predictor for complications (p = 0.053) and contralateral augmentation was not associated with development of complications. CONCLUSION: Contralateral breast augmentation in DTI breast reconstruction is not a risk factor for complications and can be safely performed in selected patients.
引用
- Park BY, Hong SE, Hong MK, et al. The influence of contralateral breast augmentation on the development of complications in direct-to-implant breast reconstruction. J Plast Reconstr Aesthet Surg. 2020. PMID: 32359856. doi:10.1016/j.bjps.2019.12.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。